Status of HPV Vaccine Introduction and Barriers to Country Uptake
This article, published in Vaccine, reports on the current status of human papillomavirus (HPV) vaccine introduction and barriers to uptake for low-and middle-income countries (LMICs). Over 60 countries have introduced HPV vaccination programs, however the majority of these countries are high or upper-middle income countries. Barriers to introduction in LMICs with the highest burden of cervical cancer remain, including structural and programmatic challenges. The authors conclude that, in the long-term, work is needed to ensure a sustainable structure of international funding and support and to strengthen health systems and immunization programs; in the short-term, if one-dose HPV vaccination became viable, some of the significant barriers to scale-up and sustained use in LMICs may be overcome.
Author: Gallagher KE, LaMontagne DS, Watson-Jones D
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Gallagher KE, LaMontagne DS, Watson-Jones D. Status of HPV Vaccine Introduction and Barriers to Country Uptake. Vaccine. 2018;Early Online Publication.
Resource types: Peer-reviewed journal
Diseases/vaccines: Human papillomavirus (HPV)